-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
The effects of lubricant eye drops on visual function as measured by the Inter-blink interval Visual Acuity Decay test
Original Research
(3595) Views (1593) Full article downloads
Authors: Gail Torkildsen
Published Date September 2009
Volume 2009:3 Pages 501 - 506
DOI: http://dx.doi.org/10.2147/OPTH.S6225
Gail Torkildsen
Andover Eye Associates, Andover, MA, USA
Objective: The purpose of the current study was to evaluate the effects of two marketed ocular lubricants on the visual decay in dry eye patients using the Inter-blink interval Visual Acuity Decay (IVAD) test.
Methods: This controlled, randomized, double-masked crossover study compared the effects of a polyethylene glycol/propylene glycol-based (PEG/PG) tear and a carboxymethylcellulose sodium (CMC)/glycerin tear on the visual acuity decay between blinks of dry eye patients. At visit 1 (Day 0), baseline IVAD measurements were recorded prior to instillation of a single drop of randomized study medication. IVAD testing was repeated at 15-, 45-, and 90-minutes post-instillation. Reading rate and functional blink rate were also evaluated. At the second visit (Day 7 ± 3), study procedures were repeated using crossover treatment.
Results: Forty-eight (48) subjects with dry eye (61.1 ± 14.8 years old, 79.2% female, 95.8% white) completed the study. Treatment with the PEG/PG-based tear demonstrated statistically significantly longer time to one-line loss of best-corrected visual acuity (BCVA) as determined by the IVAD test at 90 minutes post-instillation compared to the CMC/glycerin tear (P = 0.0365). Measurements of median time at BCVA, reading rate, and functional blink rate were similar for both treatments. Both formulations were well tolerated in the population studied.
Conclusions: Treatment with the PEG/PG-based tear demonstrated statistically significant improved maintenance of visual acuity between blinks at 90 minutes post-instillation compared to the CMC/glycerin tear. This is the first study to demonstrate the ability of an artificial tear to extend visual acuity maintenance between blinks, as measured by the IVAD test.
Keywords: dry eye, visual function, artificial tears, ocular lubricant
Readers of this article also read:
Etiology, prevalence, and treatment of dry eye disease
Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
The effect of pterygium surgery on contrast sensitivity and corneal topographic changes
Success rates in the correction of astigmatism with toric and spherical soft contact lens fittings
The use of mitomycin C with autologous limbal-conjunctival autograft transplantation for management of recurrent pterygium
Prevention of cataract in diabetic mice by topical pyruvate
Corneal collagen crosslinking in the treatment of infectious keratitis
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Insight into 144 patients with ocular vascular events during VEGF antagonist injections
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia




